A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Carrick Therapeutics announces Pfizer has invested US$35.0M to support development of samuraciclib CT-7001 in HR+, HER2- breast cancer, which accounts for more than two thirds of all new female breast cancer cases; Carrick keeps full ownership of the drug

BioNTech SE listed a new clinical trial to learn about bivalent COVID-19 RNA vaccine candidate(s) in healthy infants and children

BC study finds low but increased risk of myocarditis among young men after 2nd Moderna COVID-19 shot compared to those who got Pfizer-BioNTech vaccine; researchers found 99 cases of myocarditis out of total of 10.2 million doses that were administered

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster demonstrating improved immune response against emerging Omicron sublineages

Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster demonstrating improved immune response against emerging Omicron sublineages

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count